A detailed history of Delta Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Delta Asset Management LLC holds 100 shares of MRNA stock, worth $11,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$11,645
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $11,838 - $21,004
100 New
100 $17,000
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $12,646 - $23,505
-100 Closed
0 $0
Q3 2020

Oct 28, 2020

BUY
$54.34 - $94.85 $5,434 - $9,485
100 New
100 $7,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.